[go: up one dir, main page]

PE117199A1 - PARASITICIDE FORMULATIONS - Google Patents

PARASITICIDE FORMULATIONS

Info

Publication number
PE117199A1
PE117199A1 PE1998000903A PE00090398A PE117199A1 PE 117199 A1 PE117199 A1 PE 117199A1 PE 1998000903 A PE1998000903 A PE 1998000903A PE 00090398 A PE00090398 A PE 00090398A PE 117199 A1 PE117199 A1 PE 117199A1
Authority
PE
Peru
Prior art keywords
implant
parasiticide
parasiticide formulations
formulations
milbemycin
Prior art date
Application number
PE1998000903A
Other languages
Spanish (es)
Inventor
Hiep Huatan
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720228.7A external-priority patent/GB9720228D0/en
Priority claimed from GBGB9810143.9A external-priority patent/GB9810143D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of PE117199A1 publication Critical patent/PE117199A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UN IMPLANTE SOLIDO QUE COMPRENDE: A) AL MENOS UN COMPUESTO PARASITICIDA QUE TIENE UNA BAJA SOLUBILIDAD ACUOSA POR DEBAJO DE 100 �g/ml, Y QUE PUEDE SER AVERMECTINA, MILBEMICINA, ENTRE OTROS; Y B) EXCIPIENTES DE COMPRESION, ENTRE LOS QUE SE INCLUYE UN AGENTE DE RELLENO TAL COMO LACTOSA. EL PRESENTE IMPLANTE TIENE FORMA DE BARRITA Y ESTA ADAPTADO PARA LA IMPLANTACION EN LAS OREJAS DE VACAS U OVEJAS O CUALQUIER ANIMAL QUE LO REQUIERA, DE MANERA QUE LES PROPORCIONE PROTECCION PROLONGADA FRENTE A PARASITOSIT REFERS TO A SOLID IMPLANT THAT INCLUDES: A) AT LEAST ONE PARASITICIDE COMPOUND THAT HAS A LOW AQUEOUS SOLUBILITY BELOW 100 �g / ml, AND WHICH MAY BE AVERMECTIN, MILBEMYCIN, AMONG OTHERS; AND B) COMPRESSION EXCIPIENTS, INCLUDING A FILLING AGENT SUCH AS LACTOSE. THIS IMPLANT IS IN THE SHAPE OF A BAR AND IS ADAPTED FOR IMPLEMENTATION IN THE EARS OF COWS OR SHEEP OR ANY ANIMAL THAT REQUIRES IT, SO THAT IT PROVIDES THEM PROLONGED PROTECTION AGAINST PARASITES

PE1998000903A 1997-09-23 1998-09-22 PARASITICIDE FORMULATIONS PE117199A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9720228.7A GB9720228D0 (en) 1997-09-23 1997-09-23 Parasiticidal formulations
GBGB9810143.9A GB9810143D0 (en) 1998-05-12 1998-05-12 Parasiticidal formulations

Publications (1)

Publication Number Publication Date
PE117199A1 true PE117199A1 (en) 1999-11-20

Family

ID=26312302

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000903A PE117199A1 (en) 1997-09-23 1998-09-22 PARASITICIDE FORMULATIONS

Country Status (13)

Country Link
EP (1) EP1014970A1 (en)
JP (1) JP2001517622A (en)
AP (1) AP9801350A0 (en)
AR (1) AR013509A1 (en)
AU (1) AU9742298A (en)
BR (1) BR9812385A (en)
CA (1) CA2304283A1 (en)
GT (1) GT199800149A (en)
MA (1) MA24655A1 (en)
PA (1) PA8459501A1 (en)
PE (1) PE117199A1 (en)
TN (1) TNSN98175A1 (en)
WO (1) WO1999015166A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
US6645192B2 (en) 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
AU1556000A (en) * 1999-11-22 2001-06-04 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
DE10032878A1 (en) * 2000-07-06 2002-01-17 Bayer Ag Anthelmintics to prevent parasitic infections in humans and animals
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7918863B2 (en) 2005-06-24 2011-04-05 Conceptus, Inc. Minimally invasive surgical stabilization devices and methods
EP3634583A4 (en) * 2017-06-06 2021-03-03 Merck Sharp & Dohme Corp. LONG-ACTION IMPLANT FOR THE TREATMENT OF INFECTIOUS DISEASES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240274A3 (en) * 1986-04-03 1990-03-14 Merck & Co. Inc. Avermectins as growth promotant agents
US4847243A (en) * 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5411737A (en) * 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device

Also Published As

Publication number Publication date
CA2304283A1 (en) 1999-04-01
PA8459501A1 (en) 2000-05-24
AU9742298A (en) 1999-04-12
WO1999015166A1 (en) 1999-04-01
TNSN98175A1 (en) 2005-03-15
GT199800149A (en) 2000-03-15
BR9812385A (en) 2000-09-12
AR013509A1 (en) 2000-12-27
EP1014970A1 (en) 2000-07-05
AP9801350A0 (en) 2000-03-17
JP2001517622A (en) 2001-10-09
MA24655A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
PE20000939A1 (en) FSH FORMULATIONS AND FSH VARIANTS, PRODUCTS AND METHODS
ES2077530B1 (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS TO CURE TUMOR DISEASES.
AR044433A1 (en) REPELLENT COMPOSITION AGAINST INSECTS, METHOD FOR REDUCING THE INCIDENCE OF AN INFECTIOUS DISEASE CAUSED BY AN OBJECTIVE PEST THAT INCLUDES SUCH COMPOSITION AND ITS USES
BR0114799A (en) Cyanophenoxy carboxylic acid compounds and compositions for releasing active agents
ES2067696T3 (en) SUSTAINED RELEASE COMPOSITIONS TO TREAT PERIODONTAL DISEASE.
AR013488A1 (en) AQUEOUS GERMICIDAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF INFECTIOUS DISEASES OF ANIMAL FISH, AND USE OF SUCH COMPOSITION
BR0008405A (en) Factor viii composition formulated without the addition of albumin, use of a factor viii composition, and method of lyophilizing an aqueous pharmaceutical formulation
ES2139021T3 (en) DETERGENT-IODINE GERMICIDAL COMPOSITIONS WHICH HAVE A REDUCED DETERGENT CONTENT.
BRPI0412975A (en) penetrating foam for pharmaceutical use
PA8484301A1 (en) PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION
CR7089A (en) LIQUID FORMULATIONS FOR DERMIC APPLICATION FOR THE FIGHT AGAINST PARASITING INSECTS IN ANIMALS
ES2195169T3 (en) VACCINES AGAINST CALMIDIES AND IMMUNOGENIC COMPOSITIONS CONTAINING AN EXTERNAL MEMBRANE ANTIGEN AND METHODS FOR PREPARATION.
ES2146300T3 (en) USE OF ANTIHELMINTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS CAUSED BY ANOPLOCEPHALA PERFOLIATA IN EQUIDS.
PE117199A1 (en) PARASITICIDE FORMULATIONS
ES2162319T3 (en) USE OF THE CLIOQUINOL CHELATING AGENT FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE.
ES2063033T3 (en) USE OF IGF-II IN THE TREATMENT OF BONE DISEASES.
ES2094702B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF CANCER DISEASES AND PROCEDURE FOR THEIR PREPARATION.
AR017925A1 (en) A WATERY FORMULATION TO VERTER, TOPICALLY ACCEPTABLE, ADAPTED FOR ITS EXTERNAL APPLICATION LOCATED IN AN ANIMAL, ITS USE AND A METHOD TO FORMULATE IT
PE3096A1 (en) FORMULATION CONTAINING SELENIUM
AR021690A1 (en) USE OF KTQ1 CHANNEL INHIBITORS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES, WHICH ARE CAUSED BY YECTOPARASITES HELMENTS.
ES2036589T5 (en) A PROCEDURE FOR THE PREPARATION OF A VETERINARY COMPOSITION FOR USE IN THE TREATMENT OR PROPHYLAXIS OF BREAST ALTERATIONS IN NON-HUMAN ANIMALS.
ES2163631T3 (en) AN IMPROVED PEPTIDE, IMMUNOGENIC COMPOSITION AND VACCINE OR MEDICAL PREPARATION, A PROCEDURE TO IMMUNIZE ANIMALS AGAINST LHRH HORMONE, ANALOGS OF LHRH PEPTIDE REPEATED IN TANDEM AND ITS USE AS A VACCINE.
PA8459201A1 (en) ANTIMASTIC PHARMACEUTICAL COMPOSITION BASED ON EXTRACTS OF NATURAL ORIGIN AND PROCEDURE TO MANUFACTURE IT
ES2185310T3 (en) HERBAL ANTIVIRICAL AGENT.
MX172107B (en) PROCEDURE FOR DISINFECTION OF MASSES FOR MEDICINAL EMPTYING

Legal Events

Date Code Title Description
FD Application declared void or lapsed